Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis

International Journal of Antimicrobial Agents

Volumn 45, Issue 5, 2015, Pages 496-503

  Te Brake, Lindsey ^a   Dian, Sofiati ^b   Ganiem, Ahmad Rizal ^b   Ruesen, Carolien ^a   Burger, David ^a   Donders, Rogier ^a   Ruslami, Rovina ^b   Van Crevel, Reinout ^a   Aarnoutse, Rob ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

High dose rifampicin; Moxifloxacin; PK PD; Tuberculous meningitis

Indexed keywords

MOXIFLOXACIN; QUINOLONE DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; CHEMISTRY; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HUMAN; INDONESIA; MALE; MIDDLE AGED; PLASMA; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TUBERCULOSIS, MENINGEAL; YOUNG ADULT;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HUMANS; INDONESIA; MALE; MIDDLE AGED; PLASMA; RIFAMPIN; SURVIVAL ANALYSIS; TUBERCULOSIS, MENINGEAL; YOUNG ADULT;

EID: 84939517538     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.12.027     Document Type: Article

References (30)

1. World Health Organization Global tuberculosis report 2013 2013 WHO Geneva, Switzerland
2. G.E. Thwaites, R. van Toorn, and J. Schoeman Tuberculous meningitis: more questions, still too few answers Lancet Neurol 12 2013 999 1010
3. World Health Organization Treatment of tuberculosis: guidelines for national programmes 4th ed 2009 WHO Geneva, Switzerland
4. G. Thwaites, M. Fisher, C. Hemingway, G. Scott, T. Solomon, and J. Innes British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children J Infect 59 2009 167 187
5. P.R. Donald Cerebrospinal fluid concentrations of antituberculosis agents in adults and children Tuberculosis (Edinb) 90 2010 279 292
6. R. Ruslami, A.R. Ganiem, S. Dian, L. Apriani, T.H. Achmad, and A.J. van der Ven Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial Lancet Infect Dis 13 2013 27 35
7. J.B. Mehta, H. Shantaveerapa, R.P. Byrd Jr., S.E. Morton, F. Fountain, and T.M. Roy Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy Chest 120 2001 1520 1524
8. M. Weiner, D. Benator, W. Burman, C.A. Peloquin, A. Khan, and A. Vernon Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis Clin Infect Dis 40 2005 1481 1491
9. S. Chideya, C.A. Winston, C.A. Peloquin, W.Z. Bradford, P.C. Hopewell, and C.D. Wells Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana Clin Infect Dis 48 2009 1685 1694
10. S. Srivastava, J.G. Pasipanodya, C. Meek, R. Leff, and T. Gumbo Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability J Infect Dis 204 2011 1951 1959
11. J.G. Pasipanodya, S. Srivastava, and T. Gumbo Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy Clin Infect Dis 55 2012 169 177
12. J.G. Pasipanodya, H. McIlleron, A. Burger, P.A. Wash, P. Smith, and T. Gumbo Serum drug concentrations predictive of pulmonary tuberculosis outcomes J Infect Dis 208 2013 1464 1473
13. G.E. Thwaites, D.B. Nguyen, H.D. Nguyen, T.Q. Hoang, T.T. Do, and T.C. Nguyen Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults N Engl J Med 351 2004 1741 1751
14. G.E. Thwaites, S.M. Bhavnani, T.T. Chau, J.P. Hammel, M.E. Torok, and S.A. Van Wart Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis Antimicrob Agents Chemother 55 2011 3244 3253
15. E. Burhan, C. Ruesen, R. Ruslami, A. Ginanjar, H. Mangunnegoro, and P. Ascobat Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients Antimicrob Agents Chemother 57 2013 3614 3619
16. World Health Organization Rapid advice - treatment of tuberculosis in children 2010 WHO Geneva, Switzerland
17. R. Ruslami, H.M. Nijland, B. Alisjahbana, I. Parwati, R. van Crevel, and R.E. Aarnoutse Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients Antimicrob Agents Chemother 51 2007 2546 2551
18. R. Jayaram, S. Gaonkar, P. Kaur, B.L. Suresh, B.N. Mahesh, and R. Jayashree Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis Antimicrob Agents Chemother 47 2003 2118 2124
19. I.M. Rosenthal, R. Tasneen, C.A. Peloquin, M. Zhang, D. Almeida, and K.E. Mdluli Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis Antimicrob Agents Chemother 56 2012 4331 4340
20. J.E. de Steenwinkel, R.E. Aarnoutse, G.J. de Knegt, M.T. ten Kate, M. Teulen, and H.A. Verbrugh Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model Am J Respir Crit Care Med 187 2013 1127 1134
21. A.H. Diacon, R.F. Patientia, A. Venter, P.D. van Helden, P.J. Smith, and H. McIlleron Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears Antimicrob Agents Chemother 51 2007 2994 2996
22. K.R. Steingart, S. Jotblad, K. Robsky, D. Deck, P.C. Hopewell, and D. Huang Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review Int J Tuberc Lung Dis 15 2011 305 316
23. G. Alvarez-Uria, M. Midde, R. Pakam, and P.K. Naik Initial antituberculous regimen with better drug penetration into cerebrospinal fluid reduces mortality in HIV infected patients with tuberculous meningitis: data from an HIV observational cohort study Tuberc Res Treat 2013 2013 242604
24. D. Heemskerk, J. Day, T.T. Chau, N.H. Dung, N.T. Yen, and N.D. Bang Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial Trials 12 2011 25
25. M. Boeree, A. Diacon, R. Dawson, J. du Bois, K. Narunsky, and A. Venter What is the 'right' dose of rifampin? An interim report Fifth international workshop on clinical pharmacology of TB drugs 8 September, San Francisco, CA 2012 (abstract O-002)
26. R.K. Shandil, R. Jayaram, P. Kaur, S. Gaonkar, B.L. Suresh, and B.N. Mahesh Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy Antimicrob Agents Chemother 51 2007 576 582
27. R. Nau, F. Sorgel, and H. Eiffert Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections Clin Microbiol Rev 23 2010 858 883
28. P. Bemer-Melchior, A. Bryskier, and H.B. Drugeon Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex J Antimicrob Chemother 46 2000 571 576
29. N. Rastogi, V. Labrousse, and K.S. Goh In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages Curr Microbiol 33 1996 167 175
30. V. Yunivita, S. Dian, A.R. Ganiem, E. Hayati, R. van Crevel, and R. Ruslami Pharmacokinetic and safety/tolerability study of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients 45th Union world conference on lung health 28 October-1 November, Barcelona, Spain 2014